Cargando…

The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia

BACKGROUND: To determine the impact of COVID-19 infection in patients with chronic limb-threatening ischemia, mainly the limb salvage estimates rate and the overall survival. METHODS: This was a retrospective, consecutive cohort study of chronic limb-threatening ischemia in patients with COVID-19 in...

Descripción completa

Detalles Bibliográficos
Autores principales: de Athayde Soares, Rafael, de Arruda Cáceres, Nayara, Barbosa, Anndya Gonçalves, Matielo, Marcelo Fernando, Sacilotto, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529269/
https://www.ncbi.nlm.nih.gov/pubmed/34742566
http://dx.doi.org/10.1016/j.surg.2021.10.016
_version_ 1784586434186838016
author de Athayde Soares, Rafael
de Arruda Cáceres, Nayara
Barbosa, Anndya Gonçalves
Matielo, Marcelo Fernando
Sacilotto, Roberto
author_facet de Athayde Soares, Rafael
de Arruda Cáceres, Nayara
Barbosa, Anndya Gonçalves
Matielo, Marcelo Fernando
Sacilotto, Roberto
author_sort de Athayde Soares, Rafael
collection PubMed
description BACKGROUND: To determine the impact of COVID-19 infection in patients with chronic limb-threatening ischemia, mainly the limb salvage estimates rate and the overall survival. METHODS: This was a retrospective, consecutive cohort study of chronic limb-threatening ischemia in patients with COVID-19 infection. RESULTS: Overall, 35 patients with chronic limb-threatening ischemia and COVID-19 infection were evaluated. The mean age of the patients was 72.51 years, and most of them were male (60%), with arterial hypertension (85.7%), followed by diabetes mellitus (80%) and tobacco user (71.4%). There was a higher prevalence of wound, ischemia and foot infection (WIfI) classification 4 with 58.8% and Rutherford grade 5 (74.3%). The factors related to overall mortality rate were: D-dimer >1,000 mg/dL (hazard ratio = 22.7, P < .001, confidence interval = 10.49–26.52), respiratory symptoms (hazard ratio = 16.6, P < .001, confidence interval = 9.87–20.90), chest computed tomography compromising higher than 50% of the pulmonary tract (hazard ratio = 16,0, P < .001, confidence interval = 10.41–20.55), acute kidney failure (hazard ratio = 21.58, P < .001, confidence interval = 16.5–30.5), chronic kidney disease (hazard ratio = 4.4, P = .036, confidence interval = 1.45–10.1), therapeutic anticoagulation (hazard ratio = 8.37, P = .004, confidence interval = 1.35–8.45), and WIfI classification (hazard ratio = 5.28, P = .022, confidence interval = 1.34–10.01). The following were related to limb loss: D-dimer >1,000 mg/mL (hazard ratio = 5.47, P = .02, confidence interval = 1.94–10.52), respiratory symptoms (hazard ratio = 5.42, P = .02, confidence interval = 1.87–10.90), and WIfI classification (hazard ratio = 4.44, P = .035, confidence interval = 1.34–8.01). CONCLUSION: This study concluded that COVID-19 has a catastrophic impact among patients with chronic limb-threatening ischemia. The main factors related to overall mortality were D-dimer >1,000 mg/dL, respiratory symptoms, chest computed tomography compromising higher than 50% of the pulmonary tract, acute kidney failure, chronic kidney disease, therapeutic anticoagulation, and WIfI classification. The factors related to limb loss were WIfI classification, D-dimer >1,000 mg/mL and respiratory symptoms.
format Online
Article
Text
id pubmed-8529269
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85292692021-10-21 The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia de Athayde Soares, Rafael de Arruda Cáceres, Nayara Barbosa, Anndya Gonçalves Matielo, Marcelo Fernando Sacilotto, Roberto Surgery Vascular BACKGROUND: To determine the impact of COVID-19 infection in patients with chronic limb-threatening ischemia, mainly the limb salvage estimates rate and the overall survival. METHODS: This was a retrospective, consecutive cohort study of chronic limb-threatening ischemia in patients with COVID-19 infection. RESULTS: Overall, 35 patients with chronic limb-threatening ischemia and COVID-19 infection were evaluated. The mean age of the patients was 72.51 years, and most of them were male (60%), with arterial hypertension (85.7%), followed by diabetes mellitus (80%) and tobacco user (71.4%). There was a higher prevalence of wound, ischemia and foot infection (WIfI) classification 4 with 58.8% and Rutherford grade 5 (74.3%). The factors related to overall mortality rate were: D-dimer >1,000 mg/dL (hazard ratio = 22.7, P < .001, confidence interval = 10.49–26.52), respiratory symptoms (hazard ratio = 16.6, P < .001, confidence interval = 9.87–20.90), chest computed tomography compromising higher than 50% of the pulmonary tract (hazard ratio = 16,0, P < .001, confidence interval = 10.41–20.55), acute kidney failure (hazard ratio = 21.58, P < .001, confidence interval = 16.5–30.5), chronic kidney disease (hazard ratio = 4.4, P = .036, confidence interval = 1.45–10.1), therapeutic anticoagulation (hazard ratio = 8.37, P = .004, confidence interval = 1.35–8.45), and WIfI classification (hazard ratio = 5.28, P = .022, confidence interval = 1.34–10.01). The following were related to limb loss: D-dimer >1,000 mg/mL (hazard ratio = 5.47, P = .02, confidence interval = 1.94–10.52), respiratory symptoms (hazard ratio = 5.42, P = .02, confidence interval = 1.87–10.90), and WIfI classification (hazard ratio = 4.44, P = .035, confidence interval = 1.34–8.01). CONCLUSION: This study concluded that COVID-19 has a catastrophic impact among patients with chronic limb-threatening ischemia. The main factors related to overall mortality were D-dimer >1,000 mg/dL, respiratory symptoms, chest computed tomography compromising higher than 50% of the pulmonary tract, acute kidney failure, chronic kidney disease, therapeutic anticoagulation, and WIfI classification. The factors related to limb loss were WIfI classification, D-dimer >1,000 mg/mL and respiratory symptoms. Elsevier Inc. 2022-05 2021-10-21 /pmc/articles/PMC8529269/ /pubmed/34742566 http://dx.doi.org/10.1016/j.surg.2021.10.016 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Vascular
de Athayde Soares, Rafael
de Arruda Cáceres, Nayara
Barbosa, Anndya Gonçalves
Matielo, Marcelo Fernando
Sacilotto, Roberto
The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
title The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
title_full The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
title_fullStr The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
title_full_unstemmed The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
title_short The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
title_sort catastrophic impact of covid-19 infection in patients with chronic limb-threatening ischemia
topic Vascular
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529269/
https://www.ncbi.nlm.nih.gov/pubmed/34742566
http://dx.doi.org/10.1016/j.surg.2021.10.016
work_keys_str_mv AT deathaydesoaresrafael thecatastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT dearrudacaceresnayara thecatastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT barbosaanndyagoncalves thecatastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT matielomarcelofernando thecatastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT sacilottoroberto thecatastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT deathaydesoaresrafael catastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT dearrudacaceresnayara catastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT barbosaanndyagoncalves catastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT matielomarcelofernando catastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia
AT sacilottoroberto catastrophicimpactofcovid19infectioninpatientswithchroniclimbthreateningischemia